Bridge City Capital’s Utah Medical Products UTMD Stock Holding History

Bridge City Capital’s Portfolio UTMD Stock Details UTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$459K	Sell	6,654 -637	-9%	-$42.3K	0.1%	103
2026 Q1	$452K	Buy	7,291 +407	+6%	+$25.6K	0.13%	99
2025 Q4	$385K	Buy	6,884 +1,254	+22%	+$72.7K	0.11%	101
2025 Q3	$355K	Buy	5,630 +646	+13%	+$38.2K	0.09%	98
2025 Q2	$284K	Sell	4,984 -127	-2%	-$6.91K	0.08%	104
2025 Q1	$286K	Sell	5,111 -162	-3%	-$9.71K	0.09%	99
2024 Q4	$324K	Buy	5,273 +9	+0.2%	+$582	0.09%	102
2024 Q3	$352K	Hold	5,264	–	–	0.1%	106
2024 Q2	$352K	Buy	5,264 +709	+16%	+$48.3K	0.12%	105
2024 Q1	$324K	Buy	4,555 +1,379	+43%	+$103K	0.12%	104
2023 Q4	$267K	Buy	+3,176	New	+$263K	0.1%	102

Other funds holding UTMD

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Minerva Advisors Bala Cynwyd, Pennsylvania $158M AUM 42.05% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bridge City Capital's UTMD Position: Q2 2026 in Review

Bridge City Capital reduced its Utah Medical Products (UTMD) stake by 8.7% in Q2 2026, selling an estimated $42.3K and leaving 6,654 shares worth $459K. The position accounts for 0.1% of the portfolio, ranked #103.

Bridge City Capital first reported a position in UTMD in Q4 2023 and has held it in 11 quarters since. 114 funds tracked by Wall St. Rank hold UTMD as of Q2 2026.

Bridge City Capital held 6,654 shares of Utah Medical Products worth $459K as of Q2 2026.
Bridge City Capital sold 637 Utah Medical Products shares in Q2 2026, an estimated $42.3K.
Utah Medical Products made up 0.1% of Bridge City Capital's portfolio in Q2 2026, its #103 holding.
Bridge City Capital first reported a position in Utah Medical Products in Q4 2023 and has held it in 11 quarters since.
114 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2026.

Based on Bridge City Capital's 13F filing for Q2 2026, filed 11 Aug 2026.